Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelica M Bello

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer ProbesAngelica M Bello, Ewa Wasilewski, Lianhu Wei, et al.
Journal of Medicinal Chemistry|August 4, 2006
Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kineticsEwa Poduch, Angelica M Bello, Sishi Tang, et al.
Journal of Medicinal Chemistry|February 21, 2013
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal modelLianhu Wei, Ewa Wasilewski, Sai Kumar Chakka, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|September 4, 2014
Immunological targets in inflammation from the small molecule perspectiveAngelica M Bello, Meena K Purohit, Tracy Jun Yang Cui, et al.
Journal of Medicinal Chemistry|October 19, 2017
Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple SclerosisElizabeth J Curiel Tejeda, Angelica M Bello, Ewa Wasilewski, et al.
Cannabis and Cannabinoid Research|November 4, 2017
<i>Cannabis sativa</i> (Hemp) Seeds, Δ<sup>9</sup>-Tetrahydrocannabinol, and Potential OverdoseYi Yang, Melissa M Lewis, Angelica M Bello, et al.
Journal of the American Chemical Society|October 27, 2005
An unprecedented twist to ODCase catalytic activityMasahiro Fujihashi, Angelica M Bello, Ewa Poduch, et al.
Journal of Medicinal Chemistry|April 9, 2008
De novo design of nonpeptidic compounds targeting the interactions between interferon-alpha and its cognate cell surface receptorAngelica M Bello, Tanushree Bende, Lianhu Wei, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 25, 2015
Small Molecule Agonists for the Type I Interferon Receptor: An In Silico ApproachLianhu Wei, Angelica M Bello, Beata Majchrzak-Kita, et al.
Bioorganic & Medicinal Chemistry|January 18, 2014
Small molecule mimetics of an interferon-α receptor interacting domainAngelica M Bello, Lianhu Wei, Beata Majchrzak-Kita, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
ACS Medicinal Chemistry Letters|June 6, 2014
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer ProbesAngelica M Bello, Ewa Wasilewski, Lianhu Wei, et al.
Journal of Medicinal Chemistry|August 4, 2006
Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kineticsEwa Poduch, Angelica M Bello, Sishi Tang, et al.
Journal of Medicinal Chemistry|February 21, 2013
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal modelLianhu Wei, Ewa Wasilewski, Sai Kumar Chakka, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|September 4, 2014
Immunological targets in inflammation from the small molecule perspectiveAngelica M Bello, Meena K Purohit, Tracy Jun Yang Cui, et al.
Journal of Medicinal Chemistry|October 19, 2017
Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple SclerosisElizabeth J Curiel Tejeda, Angelica M Bello, Ewa Wasilewski, et al.
Cannabis and Cannabinoid Research|November 4, 2017
<i>Cannabis sativa</i> (Hemp) Seeds, Δ<sup>9</sup>-Tetrahydrocannabinol, and Potential OverdoseYi Yang, Melissa M Lewis, Angelica M Bello, et al.
Journal of the American Chemical Society|October 27, 2005
An unprecedented twist to ODCase catalytic activityMasahiro Fujihashi, Angelica M Bello, Ewa Poduch, et al.
Journal of Medicinal Chemistry|April 9, 2008
De novo design of nonpeptidic compounds targeting the interactions between interferon-alpha and its cognate cell surface receptorAngelica M Bello, Tanushree Bende, Lianhu Wei, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 25, 2015
Small Molecule Agonists for the Type I Interferon Receptor: An In Silico ApproachLianhu Wei, Angelica M Bello, Beata Majchrzak-Kita, et al.
Bioorganic & Medicinal Chemistry|January 18, 2014
Small molecule mimetics of an interferon-α receptor interacting domainAngelica M Bello, Lianhu Wei, Beata Majchrzak-Kita, et al.
Pageof 2